CD274 and neoplasm: Even though PD-L1 is not a perfect biomarker to predict tumor response to CPIs, high PD-L1 expression defined as 50% or more or a high tumor proportion score (TPS) often indicates a high response to immunotherapy regardless of tumor histology.